A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Prostate cancer is the most common cancer to affect American men, besides skin cancer. The American Cancer Society estimates that 1 in 8 men will be diagnosed with prostate cancer at some point in ...

Add Yahoo as a preferred source to see more of our stories on Google. Jim Hilson said his prostate cancer had ‘remained stable’ after going on the trial A “search and destroy” treatment has been found ...

This may also help explain why coupled men statistically trend toward living ...